Microtest has enhanced its analytical lab services with the installation of a new, advanced technology, MicroSeq Microbial Identification System from Applera Corp. The MicroSeq is a state-of-the-art DNA sequence-based system that enables Microtest technicians to more quickly and accurately identify bacteria isolates that are not viable or easily identified.

Using the MicroSeq system, Microtest technicians can provide precise and reliable bacteria, mycoplasma, and mold identification in a 24-hour time period, according to a company statement. Traditional bacteria and mold identification lab tests are often less accurate, and require up to a one-week turn around time.

“In the highly competitive biotechnology industry, accuracy and speed cannot be compromised,” stated Dr. Steven Richter, Microtest’s president. “Our new MicroSeq system enables our specialists to provide customers with consistent and rapid results that, unlike previous equipment, ensures that the issues and concerns that prompted our clients to undertake their testing are properly analyzed and resolved, thus putting their production back on track.”

The new system is integrated for use across the spectrum of services that Microtest provides, including contract manufacturing, pharmaceutical testing & validation, medical device testing & validation, environmental control and testing, water validation, mold identification, and biologics/virology, according to the company.